InvestorsHub Logo
Followers 840
Posts 120459
Boards Moderated 18
Alias Born 09/05/2002

Re: None

Wednesday, 10/28/2020 11:14:47 AM

Wednesday, October 28, 2020 11:14:47 AM

Post# of 768
ABBV phase-3 trials in presbyopia hit primary endpoint:

https://finance.yahoo.com/news/allergan-abbvie-company-announces-positive-120000680.html

Detailed data to be presented at an unspecified medical conference.

AGN-190584, a once-daily eye drop, was inherited from Allergan.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABBV News